{"id":450396,"date":"2019-11-21T13:18:01","date_gmt":"2019-11-21T13:18:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=450396"},"modified":"2019-11-21T13:18:01","modified_gmt":"2019-11-21T13:18:01","slug":"is-selfmonitoring-blood-glucose-devices-market-trapped-between-growth-expectations-and-uncertainty","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/is-selfmonitoring-blood-glucose-devices-market-trapped-between-growth-expectations-and-uncertainty_450396.html","title":{"rendered":"Is Self-Monitoring Blood Glucose Devices Market Trapped Between Growth Expectations and Uncertainty?"},"content":{"rendered":"
\"Is<\/a><\/p>\n
\n
Self-Monitoring Blood Glucose Devices Market <\/div>\n<\/div>\n<\/div>\n
A new research document is added in HTF MI database of 70 pages, titled as ‘Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type (Testing Strips,Glucometers, Others) End-User Type (Hospitals, Diagnostic Center and Clinics, Home Settings) and with detailed analysis, Competitive landscape, forecast and strategies. <\/div>\n

The study covers geographic analysis that includes Countries like India, China, Australia and New Zealand, Rest of Asia-Pacific and important players\/vendors such as Wockhardt, Roche Holding, Abbott Laboratories, i-SENS, Terumo Medical etc.The report will help you gain market insights, future trends and growth prospects for forecast period of 2019-2025.<\/p>\n

Request a sample report @ https:\/\/www.htfmarketreport.com\/sample-report\/2210059-asia-pacific-self-monitoring-blood-glucose-devices-market<\/a><\/strong> <\/p>\n

Summary<\/strong>
The Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the 2019-2024 period, owing to technological breakthroughs, rising obesity, and the increasing prevalence of diabetes.<\/p>\n

Product Segment Insights:<\/strong>
The testing strips segment is expected to hold the highest market share (81.64%) in 2019. Owing to the development of innovative testing strips, and a massive increase in the incidence of diabetes, this segment is expected to witness a high CAGR of 6.94% during the forecast period. The glucometers segment is expected to remain steady while generating 12% of the revenue in the Asia-Pacific market in 2019. Factors like the advantages of glucometers over regular monitoring methodologies and the production of a wide range of devices will drive this segment. However, variations in results due to external and physiological factors will lead to a comparatively low CAGR (4.95%) during the 2019-2024 period.<\/p>\n

Buy this report @ https:\/\/www.htfmarketreport.com\/buy-now?format=1&report=2210059<\/a><\/strong><\/p>\n

End User Segment Insights:<\/strong>
The shift of medical services to decentralized surroundings like patients’ homes and the development of portable and user-friendly blood glucose monitoring devices will enable the home settings segment to expand at a CAGR of 6.82% during the 2019-2024 period. The hospitals sector will generate almost 7% of the total market revenue by 2019, and is anticipated to expand at a CAGR of 4.78% during the forecast period.<\/p>\n

Country-wise Insights:<\/strong>
China and India account for half of the total diabetic population in the Asia-Pacific region. Advanced medical facilities, awareness programs, and cost-effective treatments to tackle diabetes will transform this region into the fastest-growing SMBG devices market in the world. China is expected to expand at a CAGR of 6.62% during the forecast period, while healthcare initiatives and government programs in India will enable the market in the country to expand at a CAGR of 6.46%.<\/p>\n

Companies covered:<\/strong>
• Wockhardt
• Roche Holding
• Abbott Laboratories
• i-SENS
• Terumo Medical<\/p>\n


Get Customization in the Report, Enquire Now @ https:\/\/www.htfmarketreport.com\/enquiry-before-buy\/2210059-asia-pacific-self-monitoring-blood-glucose-devices-market<\/a><\/strong> <\/p>\n

Chapter 1. Executive summary<\/strong>
1.1. Market scope and segmentation
1.2. Key questions answered in this study
1.3. Executive summary<\/p>\n

Chapter 2: Asia-Pacific self-monitoring blood glucose devices market – overview
2.1. Market definitions
2.2. Market overview
– Historical market revenue (USD Bn)
– Forecasted market revenue (USD Bn)
– Country-wise market revenue (USD Bn)
2.3. Market trends
2.4. Market drivers
2.5. Market challenges
2.6. Value chain analysis
2.7. Porter’s five forces analysis<\/p>\n

Chapter 3: Asia-Pacific self-monitoring blood glucose devices market – based on products
3.1. Testing strips
– Market overview
– Forecasted market segment reven<\/p>\n

….Continued<\/p>\n

View Detailed Table of Content @ https:\/\/www.htfmarketreport.com\/reports\/2210059-asia-pacific-self-monitoring-blood-glucose-devices-market<\/a> <\/p>\n

<\/strong>
It’s vital you keep your market knowledge up to date. If you have a different set of players\/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> HTF Market Intelligence Consulting Private Limited<\/a>
Contact Person:<\/strong> Craig Francis
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 2063171218
Address:<\/strong>Unit No. 429, Parsonage Road
City:<\/strong> Edison
State:<\/strong> New Jersey
Country:<\/strong> United States
Website:<\/strong> www.htfmarketreport.com\/reports\/2210059-asia-pacific-self-monitoring-blood-glucose-devices-market<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Self-Monitoring Blood Glucose Devices Market A new research document is added in HTF MI database of 70 pages, titled as ‘Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,412,406,443],"tags":[],"class_list":["post-450396","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-News-Current-Affairs","category-Pharmaceuticals-Biotech","category-Website-Blog"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/450396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=450396"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/450396\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=450396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=450396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=450396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}